Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14

Vaccine

Volumn 33, Issue 26, 2015, Pages 3003-3009

  Foppa, Ivo M ^a,b   Cheng, Po Yung ^a,b   Reynolds, Sue B ^a,c   Shay, David K ^a   Carias, Cristina ^d,e   Bresee, Joseph S ^a   Kim, Inkyu K ^a,b   Gambhir, Manoj ^d   Fry, Alicia M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c Atlanta Research and Education Foundation Inc   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^e Ihrc Inc   (United States)

Author keywords

Averted deaths; Bayesian analysis; Influenza; Influenza vaccine; Influenza associated mortality; Monte Carlo simulation

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG EFFICACY; HUMAN; INFANT; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; MORTALITY; NONHUMAN; PANDEMIC; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; SEASONAL INFLUENZA; UNITED STATES; AGE DISTRIBUTION; BAYES THEOREM; FEMALE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; SEASON; STATISTICS AND NUMERICAL DATA; TIME; VACCINATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BAYES THEOREM; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SEASONS; TIME FACTORS; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84930538275     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.02.042     Document Type: Article

References (61)

1. Thompson W.W., Moore M.R., Weintraub E., Cheng P.Y., Jin X., Bridges C.B., et al. Estimating influenza-associated deaths in the United States. Am J Public Health 2009, 99(Suppl. 2):S225-S230.
2. Foppa I.M., Hossain M.M. Revised estimates of influenza-associated excess mortality, United States, 1995 through 2005. Emerg Themes Epidemiol 2008, 5:26.
3. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
4. Burney L.E. Influenza immunization: statement. Public Health Rep 1960, 75:944.
5. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Morb Mortal Wkly Rep Recomm Rep 2010, 59:1. (Centers for Disease Control).
6. Kostova D., Reed C., Finelli L., Cheng P.Y., Gargiullo P.M., Shay D.K., et al. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005-2011. PLoS One 2013, 8:e66312.
7. Foppa I.M., Haber M., Ferdinands J.M., Shay D.K. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31:3104-3109.
8. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31:2165-2168.
9. Haber M., An Q., Foppa I.M., Shay D.K., Ferdinands J.M., Orenstein W.A. A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies. Epidemiol Infect 2014, 1-10.
10. Belongia E.A., Kieke B.A., Donahue J.G., Greenlee R.T., Balish A., Foust A., et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009, 199:159-167.
11. Ohmit S.E., Victor J.C., Teich E.R., Truscon R.K., Rotthoff J.R., Newton D.W., et al. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis 2008, 198:312-317.
12. Skowronski D.M., Masaro C., Kwindt T.L., Mak A., Petric M., Li Y., et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007, 25:2842-2851.
13. Skowronski D.M., De Serres G., Dickinson J., Petric M., Mak A., Fonseca K., et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009, 199:168-179.
14. Monto A.S., Ohmit S.E., Petrie J.G., Johnson E., Truscon R., Teich E., et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009, 361:1260-1267.
15. Belongia E.A., Kieke B.A., Donahue J.G., Coleman L.A., Irving S.A., Meece J.K., et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine 2011, 29:6558-6563.
16. Janjua N.Z., Skowronski D.M., De Serres G., Dickinson J., Crowcroft N.S., Taylor M., et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis 2012, 205:1858-1868.
17. Skowronski D.M., De Serres G., Crowcroft N.S., Janjua N.Z., Boulianne N., Hottes T.S., et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med 2010, 7:e1000258.
18. Griffin M.R., Monto A.S., Belongia E.A., Treanor J.J., Chen Q., Chen J., et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011, 6:e23085.
19. Treanor J.J., Talbot H.K., Ohmit S.E., Coleman L.A., Thompson M.G., Cheng P.Y., et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012, 55:951-959.
20. Ohmit S.E., Thompson M.G., Petrie J.G., Thaker S.N., Jackson M.L., Belongia E.A., et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014, 58:319-327.
21. Centers for Disease Control and Prevention (CDC). Estimated influenza illnesses and hospitalizations averted by influenza vaccination-United States, 2012-13 influenza season. MMWR Morbidity and mortality weekly report 2013;62:997-1000.
22. Reed C., Kim I.K., Singleton J.A., Chaves S.S., Flannery B., Finelli L., et al. Estimated influenza illnesses and hospitalizations averted by vaccination-United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep 2014, 63:1151-1154.
23. Frey S., Vesikari T., Szymczakiewicz-Multanowska A., Lattanzi M., Izu A., Groth N., et al. Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010, 51:997-1004.
24. Thompson MG. Updated adjusted estimates of 2012-13 seasonal influenza vaccine effectiveness in the United States advisory committee on immunization practices (ACIP), June 2013 [Meeting2013].
25. Flannery B., Thaker S.N., Clippard J., Monto A.S., Ohmit S.E., Zimmerman R.K., et al. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness-United States, February 2014. MMWR Morb Mortal Wkly Rep 2014, 63:137-142.
26. Kumar R., Burns E.A. Age-related decline in immunity: implications for vaccine responsiveness. Expert Rev Vaccines 2008, 7:467-479.
27. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, vol. 2, 2nd ed. Geneva, Switzerland; 2004.
28. Anonymous Overview of Influenza Surveillance in the United States. Centers for Disease Control and Prevention 2012.
29. R: A Language and Environment for Statistical Computing 2010, R Development Core Team, R Foundation for Statistical Computing, Vienna, Austria.
30. Poch M., Mannering F. Negative binomial analysis of intersection-accident frequencies. J Transp Eng 1996, 122:105-113.
31. Plummer M. JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling. Proceedings of the 3rd International Workshop on Distributed Statistical Computing (DSC 2003). March2003. p. 20-2.
32. Plummer M, Stukalov A, Plummer MM. Package 'rjags'. Update 2014;16:1.
33. Cameron A.S., Roder D.M., Esterman A.J., Moore B.W. Mortality from influenza and allied infections in South Australia during 1968-1981. Med J Aust 1985, 142:14-17.
34. Takahashi M., Tango T. Estimation of excess mortality associated with influenza-epidemics by age and cause specific death in Japan, 1975-1999. Nihon Eiseigaku Zasshi Jpn J Hyg 2002, 57:571-584.
35. Uphoff H., Stilianakis N.I. Influenza-associated excess mortality from monthly total mortality data for Germany from 1947 to 2000. Methods Inf Med 2004, 43:486-492.
36. Kyncl J., Prochazka B., Goddard N.L., Havlickova M., Castkova J., Otavova M., et al. A study of excess mortality during influenza epidemics in the Czech Republic, 1982-2000. Eur J Epidemiol 2005, 20:365-371.
37. Zucs P., Buchholz U., Haas W., Uphoff H. Influenza associated excess mortality in Germany, 1985-2001. Emerg Themes Epidemiol 2005, 2:6.
38. Lee V.J., Yap J., Ong J.B., Chan K.P., Lin R.T., Chan S.P., et al. Influenza excess mortality from 1950-2000 in tropical Singapore. PLoS One 2009, 4:e8096.
39. Cohen C., Simonsen L., Kang J.W., Miller M., McAnerney J., Blumberg L., et al. Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005. Clin Infect Dis 2010, 51:1362-1369.
40. Gran J.M., Iversen B., Hungnes O., Aalen O.O. Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975-2004. Epidemiol Infect 2010, 138:1559-1568.
41. Kuo H.W., Schmid D., Liu Y.L., Lachner P., Allerberger F. Influenza-related excess mortality, Austria 2001 till 2009. Wien Klin Wochenschr 2011, 123:593-598.
42. Linhart Y., Shohat T., Bromberg M., Mendelson E., Dictiar R., Green M.S. Excess mortality from seasonal influenza is negligible below the age of 50 in Israel: implications for vaccine policy. Infection 2011, 39:399-404.
43. Nielsen J., Mazick A., Glismann S., Molbak K. Excess mortality related to seasonal influenza and extreme temperatures in Denmark, 1994-2010. BMC Infect Dis 2011, 11:350.
44. Nunes B., Viboud C., Machado A., Ringholz C., Rebelo-de-Andrade H., Nogueira P., et al. Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004. PLoS One 2011, 6:e20661.
45. Freitas F.T., Souza L.R., Azziz-Baumgartner E., Cheng P.Y., Zhou H., Widdowson M.A., et al. Influenza-associated excess mortality in southern Brazil, 1980-2008. Epidemiol Infect 2012, 1-10.
46. Wu P., Goldstein E., Ho L.M., Yang L., Nishiura H., Wu J.T., et al. Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis 2012, 206:1862-1871.
47. Borse R.H., Shrestha S.S., Fiore A.E., Atkins C.Y., Singleton J.A., Furlow C., et al. Effects of Vaccine Program against Pandemic Influenza A (H1N1) Virus, United States, 2009-2010. Emerg Infect Dis 2013, 19:439.
48. Viboud C., Alonso W.J., Simonsen L. Influenza in tropical regions. PLoS Med 2006, 3:e89.
49. Cox N.J., Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 2000, 51:407-421.
50. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007, 7:658-666.
51. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994, 272:1661-1665.
52. Halloran M.E., Haber M., Longini I.M., Struchiner C.J. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol 1991, 133:323-331.
53. Anderson R.M., May R.M. Infectious Diseases of Humans: Dynamics and Control 1991, Oxford University Press, Oxford; New York.
54. Morgenstern H. Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health 1995, 16:61-81.
55. Goldstein E., Cobey S., Takahashi S., Miller J.C., Lipsitch M. Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method. PLoS Med 2011, 8:e1001051.
56. Talbot H.K., Griffin M.R., Chen Q., Zhu Y., Williams J.V., Edwards K.M. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis 2011, 203:500-508.
57. Talbot H.K., Zhu Y., Chen Q., Williams J.V., Thompson M.G., Griffin M.R. Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season. Clin Infect Dis 2013, 56:1774-1777.
58. Castilla J., Godoy P., Dominguez A., Martinez-Baz I., Astray J., Martin V., et al. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis 2013, 57(2):167-175.
59. Fry A.M., Kim I.K., Reed C., Thompson M., Chaves S.S., Finelli L., et al. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine prevented influenza associated hospitalizations in older adults. Clin Infect Dis 2014, 59(3):406-409.
60. Viboud C., Bjørnstad O.N., Smith D.L., Simonsen L., Miller M.A., Grenfell B.T. Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 2006, 312:447-451.
61. Ahluwalia I.B., Mack K.A., Murphy W., Mokdad A.H., Bales V.S. State-specific prevalence of selected chronic disease-related characteristics-Behavioral Risk Factor Surveillance System, 2001. MMWR Surveill Summ 2003, 52(8):1-80.